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Abstract 
Objective: Although a relationship between post-challenge hyperglycemia and arterial 
stiffness has been reported, the relationship between the postprandial glucose levels and 
cardio-ankle vascular index (CAVI) in non-diabetic subjects is not clear. This study thus 
evaluated the association between the postprandial glucose levels after a composite meal and 
the degree of arterial stiffness measured according to CAVI in non-diabetic subjects.  
Materials and Methods: The subjects included 1,291 individuals (655 men and 636 
women; mean age, 48.6 years; range, 23–85 years) who underwent medical examinations, 
including blood tests and CAVI assessments, between October 2005 and April 2012. The 
1-hour postprandial glucose levels were determined after a 600-kcal traditional Japanese 
meal.  
Results: The CAVI values were significantly higher in the subjects with higher 1-hour 
postprandial glucose levels (≥ 140 mg/dL in men; ≥ 158 mg/dL in women). A simple 
regression analysis indicated that the CAVI values were significantly correlated with the 
1-hour postprandial glucose levels in men (r = 0.286, p < 0.0001) and women (r = 0.228, p < 
0.0001). After adjusting for age, BMI, systolic blood pressure, triglycerides, high-density 
lipoprotein cholesterol, low-density lipoprotein cholesterol, 1-hour postprandial glucose, 
homeostasis model assessment of insulin resistance, estimated glemerular filtration rate, and 
high sensitive C-reactive protein, stepwise multiple regression analysis demonstrated that the 
1-hour postprandial glucose level was an independent predictor associated with the CAVI in 
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men (p = 0.003) and older women 50 years of age or older (p = 0.003).  
Conclusions: This study demonstrated that the 1-hour postprandial glucose levels are 
associated with increased CAVI values in non-diabetic men and older women 50 years of age 
or older.  
Key words: arterial stiffness, cardio-ankle vascular index, postprandial glucose   
 
1. Introduction 
Arterial stiffness has been demonstrated to be a surrogate marker for determining the 
prognosis of cardiovascular disease (CVD) (1). Increased arterial stiffness is an important risk 
factor for CVD morbidity and mortality, and it is very important to estimate the degree of 
arteriosclerosis by examining the level of arterial stiffness in order to take preventative 
measures against cardiovascular events (2). Arterial stiffness can be evaluated using various 
methods. Pulse-wave velocity (PWV) is a traditional parameter reflecting the degree of 
arterial stiffness, although it is affected by the patient’s blood pressure (BP) at the time of 
measurement (3). As an alternative, the cardio-ankle vascular index (CAVI), which essentially 
represents the stiffness of the aorta, femoral artery and tibial artery (4), was recently 
developed. This parameter is essentially BP-independent due to adjustment for BP based on 
the inclusion of a stiffness parameter, β (5, 6). The CAVI values have been reported to be 
increased in patients with diabetes mellitus (6, 7) and are associated with other risk factors for 
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CVD, such as hypertension (8-10), dyslipidemia (11) and smoking (12), thus reflecting the 
degree of atherosclerotic changes present in the general population and patients at high risk of 
CVD.                                                                                                                                                                 
In individuals with impaired glucose tolerance, as determined by an oral glucose 
tolerance test (OGTT), postprandial hyperglycemia increases the risk of CVD, independent of 
the fasting glucose level. The Diabetes Epidemiology: Collaborative Analysis of Diagnostic 
Criteria in Europe (DECODE) study reported the glucose concentration at two hours on 
OGTT to be a better predictor of CVD events and all-cause mortality than the fasting glucose 
level (13). In addition, the Funagata study reported that impaired glucose tolerance is a risk 
factor for CVD, but not impaired fasting glucose (14). However, most of these studies were 
based on assessments of the glucose concentration using OGTT (i.e. post-challenge blood 
glucose). The concern has been raised that OGTT testing does not involve the consumption of 
a composite meal and post-challenge hyperglycemia may only be a surrogate marker of 
postprandial hyperglycemia. The extent to which the post-challenge glucose level reflects the 
glucose concentration after a meal is not clear, as only a few studies have assessed this issue 
(15, 16). 
A relationship between post-challenge hyperglycemia and arterial stiffness has been 
reported (17-20); however, these results were obtained using OGTT and thus cannot be 
extrapolated to postprandial (i.e. after a meal) conditions, and the relationship between 
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postprandial hyperglycemia and arterial stiffness in non-diabetic populations is not clear.  
The purpose of this study was therefore to evaluate whether postprandial hyperglycemia 
is associated with the degree of atherosclerosis in non-diabetic subjects. We examined the 
association between the 1-hour postprandial glucose levels observed after eating a 600-kcal 
traditional Japanese meal and the degree of arterial stiffness measured according to the CAVI 
in non-diabetic Japanese adults. 
 
2. Materials and Methods 
2.1 Subjects 
The study subjects consisted of 1,291 individuals (655 men and 636 women) who 
underwent general health examinations between October 2005 and April 2012 at Grand Tower 
Medical Court. All participants were non-diabetic, and patients with a fasting plasma glucose 
level of ≥ 126 mg/dL or a hemoglobin A1c (HbA1c) level of ≥ 6.5% and those under 
treatment for diabetes mellitus were excluded. Another exclusion criterion was a previous 
history of CVD. The study protocol was approved by the Medical Ethics Committee of the 
Grand Tower Medical Court Life Care Clinic, and all subjects provided their written informed 
consent prior to inclusion. 
 
2.2 Anthropometric measurements and laboratory methods 
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Blood samples were obtained after overnight fasting. Blood pressure (BP) was 
measured in the sitting position on the right arm. The body mass index (BMI) was calculated 
based on the patient’s height (m) and body weight (kg). The serum lipid levels were 
determined according to an enzymatic method [total cholesterol and triglycerides, low-density 
lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) cholesterol] using a Hitachi 
7180 analyzer (Hitachi Medical, Tokyo, Japan). The plasma glucose levels were measured 
using the hexokinase method. The insulin levels were measured using a chemiluminescent 
enzyme immunoassay. The insulin resistance (HOMA-IR) was calculated using a homeostasis 
model assessment, as follows: fasting insulin (µU/mL) / (22.5eln glucose) (21). The HbA1c 
levels were determined according to an enzymatic method and as the National 
Glycohemoglobin Standardization Program (NGSP) values (22). The estimated glomerular 
filtration rate (eGFR) was used to estimate the kidney function calculated according to the 
following formulas: males: eGFR (ml min-1 1.73 m-2) = 194 × (serum creatinine)-1.094 × 
age-0.287; females: eGFR = 194 × (serum creatinine)-1.094 × age-0.287 × 0.739. The serum 
concentrations of high-sensitivity C-reactive protein (hs-CRP) were determined using a latex 
turbidimetric immunoassay. The serum levels of high-molecular-weight (HMW) adiponectin 
were measured using an enzyme-linked immunosorbent assay (Sekisui Medical, Tokyo, 
Japan) based on a monoclonal antibody for humans (23). The abdominal visceral fat area 
(VFA) and subcutaneous fat area (SFA) were measured using low-dose X-ray computed 
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tomography at the level of the navel with a Hitachi Robusto (Hitachi Medical). 
After the medical examinations, all subjects ingested a 600-kcal traditional Japanese 
meal. The composition of the meal was 20–21% protein, 15–23% fat and 56–65% 
carbohydrate with 3.5–4.0 g salt, which is typical for Japanese adults. Blood samples were 
also drawn after the start of the meal, and the plasma glucose level, in the form of the 1-hour 
postprandial glucose level, was measured.  
 
2.3 Measurement of the CAVI 
The CAVI values were recorded using a VaseraVS-1000 vascular screening system 
(Fukuda Denshi, Tokyo, Japan), as previously described (2). Briefly, cuffs were applied to the 
four extremities on both upper arms and ankles, electrocardiogram leads were attached to both 
wrists and a phonocardiogram was placed at the right sternal border in the second intercostal 
space. The subjects rested in the supine position for at least 10 minutes, and measurements 
were then performed automatically. The CAVI was calculated according to the following 
formula: CAVI = a [(2ρ/∆P) × ln(Ps/Pd) × PWV2] + b, where Ps and Pd are systolic and 
diastolic BP, respectively, in mmHg, ∆P is Ps – Pd, ρ is the blood density and a and b are 
constants to match the aortic PWV. This equation is derived from the stiffness parameter β (24, 
25) and Bramwell-Hill’s equation (26). The obtained data were analyzed using the VSS-10 
software program (Fukuda Denshi), and the right and left CAVI values were calculated. The 
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average of the two CAVI values for each side was used in the analysis. The intra-assay 
average coefficient of variation of the CAVI has been reported to be 3.8% (27), which is small 
enough for clinical use and indicates that the CAVI has good reproducibility. 
 
2.4 Statistical analysis 
Categorical variables are presented as numbers (percentage) and continuous variables 
are presented as the mean ± standard deviation or median (interquartile range). Differences in 
the clinical variables between men and women were evaluated using Student’s t-test or the 
Wilcoxon rank-sum test. As the levels of triglycerides, HOMA-IR and hs-CRP were not 
normally distributed, logarithmic transformation was performed for the analysis. The 
association between the CAVI values and the postprandial glucose quintiles was evaluated 
using Dunnett’s test, taking multiplicity into account. A simple regression analysis was 
performed to evaluate the relationships between the CAVI values and various clinical 
parameters in both sexes. A stepwise multiple regression analysis was then performed to 
evaluate the independent determinants of the CAVI values using age, BMI, systolic BP, 
triglycerides, HDL cholesterol, LDL cholesterol, 1-hour postprandial glucose, HOMA-IR, 
eGFR and hs-CRP as covariates in both sexes. Additionally, a stepwise multiple regression 
analysis was performed in the younger (under 50 years of age) and older (50 years of age or 
older) women because the median age of menopause in Japanese women is almost 50 years 
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(28). Comparisons of the VFA, HMW adiponectin, and hs-CRP levels according to the 1-hour 
postprandial glucose levels were performed using Student’s t-test. All statistical analyses were 
performed using the JMP (version 8) statistical software package (SAS Institute, Cary, USA). 
A P-value of < 0.05 was considered to be statistically significant. 
 
3. Results 
Table 1 shows the clinical characteristics of the subjects. The study subjects included 
1,291 individuals comprised of 655 men (mean age, 48.5 years; range, 23–84 years) and 636 
women (mean age, 48.7 years; range 23–85 years). The serum triglycerides, LDL cholesterol, 
hs-CRP, fasting plasma glucose and HbA1c levels and BMI, systolic and diastolic BP, 
HOMA-IR, VFA and CAVI values were significantly higher in the men than in the women. In 
contrast, the HDL cholesterol and HMW adiponectin levels and SFA and eGFR values were 
significantly lower in the men than in the women. The 1-hour postprandial glucose levels 
were not significantly different between the men and women. 
Fig. 1 shows the CAVI values according to the quintiles (Q) of the 1-hour postprandial 
glucose level. We classified the subjects according to five quintiles for men and women 
respectively; therefore, the classification differed between the sexes. In men, the quintiles of 
the 1-hour postprandial glucose level were classified as follows: Q1, ≤ 106; Q2, 107–122; Q3, 
123–139; Q4, 140–157; and Q5, ≥ 158 mg/dL. The CAVI values in the Q4 and Q5 groups 
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were significantly higher than those observed in the Q1 group in men (p = 0.01 and p <0.0001, 
respectively). In women, the quintiles of the 1-hour postprandial glucose level were classified 
as follows: Q1, ≤ 109; Q2, 110–124; Q3, 125–139; Q4, 140–157; and Q5, ≥ 158 mg/dL. The 
CAVI values in the Q5 group were significantly higher than those observed in the Q1 group in 
women (p < 0.0001). 
The simple regression analysis (Table 2) showed that the CAVI values were 
significantly correlated with the postprandial glucose levels in both men (r = 0.286, p < 
0.0001) and women (r = 0.228, p < 0.0001). As for other clinical variables, the CAVI values 
were significantly correlated with age, BMI, systolic and diastolic BP, VFA, SFA, HMW 
adiponectin, fasting plasma glucose, HbA1c, HOMA-IR, eGFR and hs-CRP in men and age, 
BMI, systolic and diastolic BP, triglycerides, LDL cholesterol, VFA, SFA, fasting plasma 
glucose and HbA1c in women.  
Table 3 shows the results of the stepwise multiple regression analysis of the CAVI and 
clinical variables in both men and women. In men, the 1-hour postprandial glucose level 
remained an independent predictor of an increased CAVI value (P=0.003), in addition to age, 
BMI, systolic BP and HDL cholesterol. In women, only age, BMI, triglycerides and 
HOMA-IR were found to be independently associated with the CAVI values. A stepwise 
multiple regression analysis was performed to determine the predictors of the CAVI values in 
the groups of younger and older women. In the group of older women, the 1-hour 
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postprandial glucose level remained an independent factor for an increased CAVI value 
(P=0.003), in addition to age, BMI, systolic BP and triglycerides. Hence, in the group of 
younger women, age, BMI and triglycerides remained independent factors for an increased 
CAVI value, but not the 1-hour postprandial glucose level (Table 4). 
Fig. 2 shows the results of the comparisons of the VFA, HMW adiponectin and hs-CRP 
levels according to the 1-hour postprandial glucose levels. The 1-hour postprandial glucose 
levels were classified as follows: normal group < 140, high group ≥ 140 mg/dL in men; and 
normal group < 158, high group ≥ 158 mg/dL in women. In both sexes, the VFA and hs-CRP 
levels in the high group were significantly higher than those observed in the normal group. In 
contrast, the HMW adiponectin levels were not significantly different between the two 
groups. 
 
4. Discussion 
In this study, we evaluated whether postprandial hyperglycemia is associated with the 
degree of atherosclerosis in non-diabetic subjects. The important difference in our study from 
other glucose-loading studies is that we prepared a 600-kcal traditional Japanese meal for all 
1,291 subjects that met the characteristics of a typical daily meal for Japanese adults and 
subsequently evaluated the association between the postprandial glucose levels and degree of 
arterial stiffness measured according to the CAVI. Our results showed the 1-hour postprandial 
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glucose levels to be positively correlated with the CAVI values in both sexes and an 
independent predictor of increased CAVI values in men and older women, after adjusting for 
age and other variables. These findings indicate that postprandial hyperglycemia is one of the 
most important factors significantly associated with the extent of atherosclerosis in 
non-diabetic subjects.  
This study is meaningful and original for the following reasons. First, the postprandial 
glucose levels were determined 60 minutes after a meal. The glucose concentration peaks at 
approximately 60 minutes after the start of a meal in healthy individuals (29); therefore, we 
measured the 1-hour postprandial glucose level. The 1-hour postprandial glucose level may 
reflect the effects of plasma glucose excursions associated with meals in everyday life among 
non-diabetic subjects and differs from the glucose concentrations measured on OGTT. Second, 
all subjects ingested a 600-kcal traditional Japanese meal, the composition of which was 
typical for Japanese adults. According to the National Health and Nutrition Survey of Japan 
conducted in 2010, the average energy intake for Japanese individuals 20 years of age or older 
is 1,859 kcal, while that for main nutrients is 68.1 g (14.7%) of protein, 52.7 g (25.5%) of fat, 
and 259.8 g (55.9%) of carbohydrate. Furthermore, no reports are available on the 
relationship between the postprandial glucose level measured after a composite meal and the 
degree of arterial stiffness determined according to the CAVI in non-diabetic subjects. Third, 
the number of non-diabetic subjects was sufficiently large, and there were no differences in 
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age or the 1-hour postprandial glucose levels between men and women. Fourth, the CAVI was 
measured as a marker of arterial stiffness in this study. The CAVI is a newly developed 
marker of arterial stiffness, considered to reflect the degree of atherosclerosis. The CAVI is 
easily measured clinically with good reproducibility and is a useful parameter for physicians 
and in subjects with masked hypertension because it is not affected by the patient’s blood 
pressure at the time of measurement.  
Our findings indicate that postprandial hyperglycemia plays an important role in 
increasing the CAVI values in older women. In women, menopause may affect the 
progression of atherosclerosis. Takahashi et al. (30) reported that menopause augments the 
age-related increase in arterial stiffness. The median age of menopause among Japanese 
women has been reported to be almost 50 years (28). We therefore divided the subjects into 
two groups using the threshold of 50 years of age in this study. However, we were unable to 
clearly obtain data for the menopause status. Further studies are thus needed to evaluate the 
association between postprandial hyperglycemia and arterial stiffness measured using the 
CAVI in non-diabetic postmenopausal women. 
The American Diabetes Association has stated that the issue of whether postprandial 
hyperglycemia is an independent risk factor for cardiovascular disease remains controversial 
and requires additional studies (29). Few studies have specifically evaluated the 
cardiovascular risks associated with postprandial hyperglycemia in patients with type 2 
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diabetes. The Diabetes Intervention Study recently reported the role of postprandial blood 
glucose in predicting cardiovascular events in newly diagnosed type 2 diabetic patients (15). 
Elevation of the blood glucose level after breakfast, but not the fasting blood glucose level, 
has been found to predict myocardial infarction and mortality, and The San Luigi Gonzaga 
Diabetes Study demonstrated the independent predictive power of postprandial glucose on 
cardiovascular events in patients with type 2 diabetes (16). In these studies, the study 
populations consisted of treated type 2 diabetes mellitus patients, and the postprandial glucose 
levels were measured under different conditions because the composition of the meals 
differed in each subject. In contrast, our study included only non-diabetic subjects, all of 
whom ingested a standardized 600-kcal Japanese meal. In addition, the CAVI values were 
significantly correlated with the 1-hour postprandial glucose levels in both sexes, and the 
1-hour postprandial glucose level was found to be one of the most significant factors 
independently associated with the CAVI values in men and older women. We therefore 
suggest that our findings provide potentially useful information regarding the atherosclerotic 
and cardiovascular risks associated with postprandial hyperglycemia.          
Several studies have reported the mechanism by which postprandial hyperglycemia 
increases vascular stiffness. Nitric oxide (NO) is considered to play an important role in 
relaxing vascular smooth muscle cells by reducing the probability of calcium 
channel-dependent activation of the sarcoplasmic reticulum, which in turn decreases Ca2+ 
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influx (31). Acute hyperglycemia is associated with increased oxidative stress, which 
inactivates NO in vitro (32, 33), and the levels of oxidative stress under intermittently high 
glucose conditions are significantly greater than those observed under constantly high glucose 
conditions in vitro (34). The CAVI is a sensitive physiological index for monitoring the degree 
of stress on the arterial wall induced by a high level of blood glucose. The results of this study 
indicate that the intermittent hyperglycemia observed after meals in everyday life induces 
impaired NO bioactivity and impacts the increase in the CAVI, even in non-diabetic 
populations.  
The VFA and hs-CRP values were significantly higher in the high postprandial glucose 
group than in the normal group in both sexes in the current study. The VFA is considered to 
play an important role in the onset of metabolic syndrome and atherosclerosis (35, 36), which 
is affected by age, gender and the level of obesity (37, 38). CRP is an inflammatory biomarker 
and strong independent predictor of diabetes (39) reported to be strongly correlated with 
metabolic risk factors (40). However, there were no significant differences in the HMW 
adiponectin levels between the normal and high postprandial glucose groups among both men 
and women in this study. Adiponectin is secreted by adipose tissue, which has anti-diabetic, 
anti-atherosclerotic, and anti-inflammatory biofunctions (41, 42). The HMW adiponectin level 
is a more useful marker for evaluating the degree of insulin resistance and metabolic 
syndrome (43). The subjects in this study were non-diabetic and relatively young. In addition, 
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few of the subjects were excessively obese, and the visceral fat area in women was half that 
observed in men. We speculate that these characteristics may have affected the relationship 
between postprandial hyperglycemia and adiponectin noted in this study.  
The BMI values were negatively correlated with the CAVI values in men and women in 
this study. A high CAVI is associated with obesity, although some studies have reported a 
negative correlation between the BMI and CAVI. Park et al. reported that the amount of 
visceral adipose tissue and epicardial adipose tissue exhibits a significant correlation with the 
CAVI, whereas BMI is negatively correlated with the CAVI (44). Meanwhile, Choi et al. 
reported that visceral obesity is a possible risk factor for arterial stiffness, rather than general 
obesity (45). In the current study, the proportion of subjects with general obesity (BMI > 25) 
was low (37.0% in men and 14.3% in women), the VFA in women was half that observed in 
men and the SFA in women was higher than that seen in men. We again speculate that these 
characteristics and/or the number of obese subjects with lower visceral fat area values in this 
study may have affected the relationship between the BMI and CAVI values.  
The HDL cholesterol levels in men and women and the LDL cholesterol and triglycerides 
levels in men did not display any significant associations with the CAVI values in this study. 
The CAVI and dyslipidemia are likely not closely connected, and dyslipidemia per se does not 
immediately increase arterial stiffness. Takaki et al. reported that the CAVI has a poor 
relationship with both the total and LDL cholesterol levels, and there is no observed 
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correlation between the CAVI values and triglyceride and HDL cholesterol levels (9). Satoh et 
al. reported that an increased CAVI is significantly correlated with the triglycerides and HDL 
cholesterol levels in men, but not women (46). This observation may reflect a difference in 
the pathophysiological mechanisms underlying dyslipidemia between men and women.  
The limitations of this study are that causality between postprandial glucose and arterial 
stiffness could not be established because our data were cross-sectional. Longitudinal and 
interventional studies are thus needed to evaluate whether a reduction in the postprandial 
glucose level decreases arterial stiffness and helps to prevent future CVD events. Additionally, 
although the rate of active smoking was higher for men than for women (32.7% and 8.1%, 
respectively), there were no significant correlations between active smoking and the CAVI 
values in men (r = 0.023, p = 0.2436) or women (r = 0.013, p = 0.3452). Kubozono et al. 
reported that smoking is associated with a significant increase in arterial stiffness as measured 
by according to the brachial artery PWV and CAVI (12). Therefore, the results of this study 
may have been affected by the fact that ex-smokers were included as smokers. Unfortunately, 
we were unable to obtain details for these patients. Furthermore, we found that 10.7% and 
7.1% of the subjects had been treated with medications for hypertension and dyslipidemia, 
respectively. Several blood pressure-lowering (47, 48) and lipid-lowering (49, 50) agents have 
been reported to decrease the CAVI. These factors may have influenced the CAVI values in 
this study and should be taken into account in future studies.  
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In conclusion, we demonstrated that the 1-hour postprandial glucose level measured after 
the consumption of a standardized composite meal (a 600-kcal traditional Japanese meal) is 
associated with increased CAVI values in non-diabetic men and older women 50 years of age 
or older. The results of this study indicate that the occurrence of postprandial hyperglycemia 
in everyday life may demonstrate an important association with the degree of atherosclerosis 
in non-diabetic subjects.  
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Figure legends 
Figure 1 - CAVI values according to the quintiles of the 1-hour postprandial glucose levels in 
men and women.  
The quintiles of 1-hour PPG (in mg/dL) were classified as follows: men: Q1, ≤ 106; Q2, 
107–122; Q3, 123–139; Q4, 140–157; and Q5, ≥ 158; and women: Q1, ≤ 109; Q2, 110–124; 
Q3, 125–139; Q4, 140–157; and Q5, ≥ 158. The data are shown as the mean ± SD. 
In men, the CAVI values were significantly higher in the Q4 and Q5 groups than in the Q1 
group. In women, the CAVI values were significantly higher in the Q5 group than in the Q1 
group. 
*p < 0.05 vs. Q1, **p < 0.0001 vs. Q1. 
 
Figure 2 - Comparison of the VFA, HMW adiponectin and hs-CRP levels according to the 
1-hour postprandial glucose levels in men and women. 
The 1-hour postprandial glucose levels were classified as follows: normal group < 140, high 
group ≥ 140 mg/dL in men; and normal group < 158, high group ≥ 158 mg/dL in women. 
Black bar: VFA in the normal group. Gray bar: VFA in the high group. 
The VFA and hs-CRP levels were significantly higher in the high group than in the normal 
28 
 
group. There were no significant differences in the HMW adiponectin levels between the two 
groups. 
*p < 0.0001, **p < 0.001, ***p < 0.05. 
§ Log-transformed values.  
 
 
 
Intern Med 54: 1961-1969, 2015 (DOI: 10.2169/internalmedicine.54.3596) 
https://www.jstage.jst.go.jp/browse/-char/ja/ 
© 2015 The Japanese Society of Internal Medicine 
Table 1 - Clinical characteristics of the subjects 
 
Men (n = 655) Women (n = 636) p value  
Age (y) 48.5 ± 10.7 48.7 ± 12.3 0.6888 
BMI (kg/m2) 24.0 ± 3.4 21.1 ± 3.1 < 0.0001 
Systolic BP (mmHg) 122.8 ± 15.0 117.0 ± 15.5 < 0.0001 
Diastolic BP (mmHg) 77.7 ± 9.9 72.2 ± 9.9 < 0.0001 
Triglyceride (mg/dL) 120.0 (82 - 121) 71.0 (52.0 - 99) < 0.0001 
HDL cholesterol (mg/dL) 56.4 ± 13.8 69.4 ± 15.3 < 0.0001 
LDL cholesterol (mg/dL) 126.1 ± 31.6 120.2 ± 31.5 0.0008 
VFA (cm2) 90.8 ± 46.9  41.5 ± 29.8 < 0.0001 
SFA (cm2) 131.9 ±62.6 147.7 ± 70.0 < 0.0001 
HMW adiponectin (μg/mL) 1.2 (0.5 - 2.1) 3.6 (1.9 – 5.2) < 0.0001 
HbA1c (%) 5.5 ± 0.5 5.4 ± 0.3 < 0.0001 
HOMA-IR  1.75 (1.14 - 2.60) 1.22 (0.86 - 1.80) 0.0002 
Fasting plasma glucose (mg/dL) 105.1 ± 14.8 95.9 ± 9.8 < 0.0001 
1-hour postprandial glucose (mg/dL) 133.8 ± 35.7 133.8 ± 29.1 0.9925 
eGFR 76.3 ± 13.4 78.4 ± 15.0 0.0072 
hsCRP (mg/L)  0.076 (0.04 - 0.158) 0.038 (0.023 – 0.078) < 0.0001 
CAVI 7.4 ± 0.9 7.2±0.9 < 0.0001 
Hypertension (n, %) 114 (17.4) 63 (9.9) 0.0312 
Hyperlipidemia (n, %) 74 (11.3) 48 (7.5) 0.6638 
Smoking (n, %) 214 (32.7) 51 (8.1) < 0.0001 
 
 
Data are presented as number of subjects, mean ± standard deviation, or median 
(interquartile range). BMI, body mass index; BP, blood pressure; HDL, high-density 
lipoprotein; LDL, low-density lipoprotein; VFA, visceral fat area; SFA, subcutaneous 
fat area; HMW, high molecular weight; HOMA, homeostasis model assessment for 
insulin resistance; eGFR, estimated glomerular filtration rate; hsCRP, high-sensitivity 
C-reactive protein; CAVI, cardio-ankle vascular index 
 
Table 2 - Correlation between CAVI and clinical variables in men and women 
 
 
Men 
 
Women 
 
 
r p value r p value 
Age (years) 0.612 < 0.0001 0.670 < 0.0001 
BMI (kg/m2) -0.17 < 0.0001 -0.149 0.0001 
Systolic BP (mmHg) 0.091 0.0113 0.243 < 0.0001 
Diastolic BP (mmHg) 0.067 0.047 0.162 < 0.0001 
Triglyceride (mg/dL) §  -0.033 0.1904 0.291 < 0.0001 
HDL cholesterol (mg/dL) 0.026 0.4582 0.038 0.7597 
LDL cholesterol (mg/dL) -0.129 0.2926 0.15 < 0.0001 
VFA (cm2) 0.138 0.0002 0.263 < 0.0001 
SFA (cm2) -0.076 < 0.0001 -0.229 0.0296 
HMW adiponectin (μg/mL) § 0.125 < 0.0001 -0.036 0.661 
Fasting plasma glucose (mg/dL) 0.181 < 0.0001 0.187 < 0.0001 
1-hour postprandial glucose (mg/dL) 0.286 < 0.0001 0.228 < 0.0001 
HbA1c (%) 0.18 < 0.0001 0.23 < 0.0001 
HOMA-IR §   0.096 0.0084 -0.033 0.5823 
eGFR -0.274 < 0.0001 -0.310 < 0.0001 
hsCRP § 0.074 0.0338 0.046 0.1258 
Smoking  0.023 0.2436 0.013 0.3452 
 
Abbreviations are the same as in Table 1. 
§ Log-transformed values. 
 
Table 3 - Stepwise multiple regression analysis between CAVI and clinical variables in 
men and women 
 
 
Men 
 
Women 
 
 
β p value β p value 
Age (years) 0.049 < 0.0001 0.052 < 0.0001 
BMI (kg/m2) -0.077 < 0.0001 -0.107 < 0.0001 
Systolic BP (mmHg) 0.005 0.012 
  
Triglyceride (mg/dL) § 
  
0.794 < 0.0001 
HDL cholesterol (mg/dL) -0.008 0.001 
  
1-hour postprandial glucose (mg/dL) 0.003 0.003 
  
HOMA-IR§ 
  
-0.313 0.016 
Adjusted R2 0.43 
 
0.54 
 
 
Abbreviations are the same as in Table 1. 
§ Log-transformed values. 
 
Table 4 - Stepwise multiple regression analysis between CAVI and clinical variables in 
younger and older women 
 
 
Younger women 
(n=274)  
Older women 
(n=362)  
 
β p value β p value 
Age (years) 0.033 < 0.0001 0.056 < 0.0001 
BMI (kg/m2) -0.073 < 0.0001 -0.115 < 0.0001 
Systolic BP (mmHg) 
  
0.006 0.039 
Triglyceride (mg/dL) § 0.828 < 0.0001 0.713 0.002 
1-hour postprandial glucose (mg/dL) 
  
0.004 0.003 
Adjusted R2 0.23 
 
0.45 
 
 
The age of younger women was under 50, and the age of older women was 50 or older. 
Abbreviations are the same as in Table 1. 
§ Log-transformed values. 
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